Rockwell Medical (RMTI) Net Margin (2010 - 2026)

Rockwell Medical has reported Net Margin for 17 years, with the latest figure at 9.95% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 164.0% year-over-year to 9.95%; the trailing twelve-month figure through Mar 2026 stood at 8.47% (down 807.0% YoY), and the FY2025 full-year result was 8.06%, down 751.0% from the prior year.
• Net Margin for Q1 2026 stood at 9.95%, down from 3.49% in the prior quarter.
• The five-year high for Net Margin was 5.88% in Q3 2024, with the low at 44.44% in Q1 2022.
• Historically, Net Margin has averaged 11.5% across 5 years, with a median of 8.9% in 2023.
• Annual changes were most pronounced in 2022 — Net Margin jumped 4609 bps — and 2025, when it tumbled 1727 bps.
• Rockwell Medical's Net Margin stood at 12.23% in 2022, then surged by 40 bps to 7.3% in 2023, then soared by 57 bps to 3.16% in 2024, then dropped by 10 bps to 3.49% in 2025, then plunged by 185 bps to 9.95% in 2026.
• The last three Net Margin figures came in at 9.95% (Q1 2026), 3.49% (Q4 2025), and 11.39% (Q3 2025), per Business Quant data.